CheckMyRecalls

Chiesi USA, Inc. recalls CLEVIPREX (clevidipine injectable emulsion)…

Chiesi USA, Inc. recalls CLEVIPREX (clevidipine injectable emulsion) 50 mg/100 mL (0.5 mg/mL)

Published
22 Jul 2026
Units affected
44280 vials
Agency
FDA
Country
United States

The hazard

Lack of Assurance of Sterility

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

CLEVIPREX (clevidipine injectable emulsion) 50 mg/100 mL (0.5 mg/mL), 10 Single Use Vials, Rx Only, Manufactured for: Chiesi USA, Inc., Cary, NC 27518, by Fresenius Kabi, Graz, Austria, NDC 10122-611-10.

Brand / company
Chiesi USA, Inc.
Codes / lots
Lot #: 1239521, 1237454, Exp. Date 10/2027
Distribution
Nationwide within the United States
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 22 Jul 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.